Annual Operating Expenses
$8.83 M
-$1.71 M-16.19%
31 December 2023
Summary:
Monopar Therapeutics annual total operating expenses is currently $8.83 million, with the most recent change of -$1.71 million (-16.19%) on 31 December 2023. During the last 3 years, it has risen by +$2.32 million (+35.68%). MNPR annual operating expenses is now -46.81% below its all-time high of $16.60 million, reached on 31 December 2017.MNPR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$1.57 M
-$213.90 K-11.96%
30 September 2024
Summary:
Monopar Therapeutics quarterly total operating expenses is currently $1.57 million, with the most recent change of -$213.90 thousand (-11.96%) on 30 September 2024. Over the past year, it has dropped by -$491.10 thousand (-23.77%). MNPR quarterly operating expenses is now -89.43% below its all-time high of $14.90 million, reached on 30 September 2017.MNPR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.2% | -23.8% |
| 3 y3 years | +35.7% | -36.0% |
| 5 y5 years | +165.1% | +107.4% |
MNPR Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.2% | +35.7% | -45.9% | at low |
| 5 y | 5 years | -16.2% | +165.1% | -45.9% | +107.4% |
| alltime | all time | -46.8% | +640.4% | -89.4% | +321.3% |
Monopar Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.57 M(-12.0%) |
| June 2024 | - | $1.79 M(+3.8%) |
| Mar 2024 | - | $1.72 M(-9.9%) |
| Dec 2023 | $8.83 M(-16.2%) | $1.91 M(-7.5%) |
| Sept 2023 | - | $2.07 M(-11.3%) |
| June 2023 | - | $2.33 M(-7.8%) |
| Mar 2023 | - | $2.52 M(-13.2%) |
| Dec 2022 | $10.54 M(+15.4%) | $2.91 M(+20.8%) |
| Sept 2022 | - | $2.41 M(-12.9%) |
| June 2022 | - | $2.76 M(+12.5%) |
| Mar 2022 | - | $2.46 M(-8.4%) |
| Dec 2021 | $9.13 M(+40.2%) | $2.68 M(+9.0%) |
| Sept 2021 | - | $2.46 M(+17.5%) |
| June 2021 | - | $2.09 M(+10.4%) |
| Mar 2021 | - | $1.89 M(-16.2%) |
| Dec 2020 | $6.51 M | $2.26 M(+37.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $1.65 M(+12.6%) |
| June 2020 | - | $1.46 M(+28.9%) |
| Mar 2020 | - | $1.14 M(-7.3%) |
| Dec 2019 | $4.32 M(+29.8%) | $1.22 M(+61.3%) |
| Sept 2019 | - | $759.40 K(-18.5%) |
| June 2019 | - | $932.10 K(-33.8%) |
| Mar 2019 | - | $1.41 M(+51.9%) |
| Dec 2018 | $3.33 M(-79.9%) | $926.40 K(+38.8%) |
| Sept 2018 | - | $667.50 K(-20.5%) |
| June 2018 | - | $840.00 K(-6.4%) |
| Mar 2018 | - | $897.30 K(+21.8%) |
| Dec 2017 | $16.60 M(+1291.9%) | $736.80 K(-95.1%) |
| Sept 2017 | - | $14.90 M(+2403.8%) |
| June 2017 | - | $595.00 K(+59.2%) |
| Mar 2017 | - | $373.80 K |
| Dec 2016 | $1.19 M | - |
FAQ
- What is Monopar Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Monopar Therapeutics?
- What is Monopar Therapeutics annual operating expenses year-on-year change?
- What is Monopar Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly operating expenses year-on-year change?
What is Monopar Therapeutics annual total operating expenses?
The current annual operating expenses of MNPR is $8.83 M
What is the all time high annual operating expenses for Monopar Therapeutics?
Monopar Therapeutics all-time high annual total operating expenses is $16.60 M
What is Monopar Therapeutics annual operating expenses year-on-year change?
Over the past year, MNPR annual total operating expenses has changed by -$1.71 M (-16.19%)
What is Monopar Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of MNPR is $1.57 M
What is the all time high quarterly operating expenses for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly total operating expenses is $14.90 M
What is Monopar Therapeutics quarterly operating expenses year-on-year change?
Over the past year, MNPR quarterly total operating expenses has changed by -$491.10 K (-23.77%)